Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Ajay Aggarwal

Anesthesiology Lake Jackson, TX Medical Doctor

NPI 1467413567 CMS profile 156740

208 Oak Dr S, Ste 500, Lake Jackson, TX 77566

Open in the dashboard

General payments

$41,774

16 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Ajay Aggarwal of Lake Jackson, TX is reported in the CMS Open Payments database as having received $41,774 across 16 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $18 1
2021 General $236 7
2020 General $32 2
2019 General $41,487 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ajay Aggarwal
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Ajay Aggarwal were reported at $0. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Ajay Aggarwal Anesthesiology median Middle half National median
2019 $41,487 $72 $23–$151 $163
2020 $32 $36 $17–$120 $114
2021 $236 $49 $21–$135 $132
2022 $18 $52 $22–$144 $149
2023 $0 $53 $23–$143 $160
2024 $0 $55 $25–$150 $164
2025 $0 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Allergan Inc. $41,408 1 payment
  2. Epimed International, Inc $116 1 payment
  3. Indivior Inc. $63 3 payments
  4. Horizon Therapeutics plc $53 3 payments
  5. Nevro Corp. $27 1 payment
  6. GRT US Holding, Inc. $24 1 payment
  7. Metacel Pharmaceuticals LLC $18 1 payment
  8. Eisai Inc. $16 1 payment
  9. Uswm, LLC $14 1 payment
  10. US WorldMeds, LLC $13 1 payment
  11. Other $22 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Gift $41,408 1 payment
  2. Food and Beverage $366 15 payments
Products named General payments · program years 2019–2022
  1. BOTOX COSMETIC $41,408 1 payment
  2. Catheters and Needles $116 1 payment
  3. SUBLOCADE $63 3 payments
  4. PENNSAID $40 2 payments
  5. Senza Spinal Cord Stimulation System $27 1 payment
  6. Qutenza $24 1 payment
  7. Ozobax $18 1 payment
  8. Dayvigo $16 1 payment
  9. Lucemyra $14 1 payment
  10. Lucemyra/Lofexidine $13 1 payment
  11. Other $44 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 42 drugs

Part D claims

5,630

Median for Anesthesiology: 322

Drug cost

$146,089

Median for Anesthesiology: $8,738

Branded share of claims

35.8%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 1,421 $39,915
Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl Brand 140 $19,212
Suboxone Buprenorphine Hcl/Naloxone Hcl Brand 27 $12,856
Movantik Naloxegol Oxalate Brand 29 $11,012
Linzess Linaclotide Brand 12 $5,909
Gabapentin Generic 405 $5,102
Tramadol Hcl Generic 590 $4,545
Xtampza Er Oxycodone Myristate Brand 13 $4,365
Methocarbamol Generic 355 $4,095
Acetaminophen-Codeine Acetaminophen With Codeine Brand 228 $3,761

The 10 drugs with the highest cost, of 42 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$97,303

Medicare's payments for the services billed

Medicare patients

98

Average age 69

Services billed

2,166

56 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 38%
Diabetes 37%
Ischemic heart disease 36%
Heart failure 34%
Chronic kidney disease 33%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

16 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record